Published in Gene Therapy Weekly, October 14th, 2004
Additionally, the company announced that it has initiated a partnership with Euroscreen, which will use Cisbio's HTRF cAMP assay for the validation of Euroscreen's recombinant cell lines and membranes expressing Gi and Gs coupled receptors (GPCR).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.